Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital

Background: Cervical cancer is the second most common of malignancy found in Thai women. Human papillomavirus (HPV) infection is a major cause. The objective of the present study was to evaluate the prevalence of HPV infection and association with abnormal cervical cytology in Thai women. Materials...

Full description

Saved in:
Bibliographic Details
Published in:Asian Pacific journal of cancer prevention : APJCP 2016, Vol.17 (9), p.4409-4413
Main Authors: Muangto, Teerapat, Chanthasenanont, Athita, Lertvutivivat, Supapen, Nanthakomon, Tongta, Pongrojpaw, Densak, Bhamarapravatana, Kornkarn, Suwannarurk, Komsun
Format: Article
Language:Korean
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4413
container_issue 9
container_start_page 4409
container_title Asian Pacific journal of cancer prevention : APJCP
container_volume 17
creator Muangto, Teerapat
Chanthasenanont, Athita
Lertvutivivat, Supapen
Nanthakomon, Tongta
Pongrojpaw, Densak
Bhamarapravatana, Kornkarn
Suwannarurk, Komsun
description Background: Cervical cancer is the second most common of malignancy found in Thai women. Human papillomavirus (HPV) infection is a major cause. The objective of the present study was to evaluate the prevalence of HPV infection and association with abnormal cervical cytology in Thai women. Materials and Methods: This study was conducted at the Gynecologic Clinic, Thammasat University, Pathum Thani, Thailand. A total of 2,144 cases who underwent annual cervical cancer screening by co-testing (liquid based cytology and HPV testing, DNA versus mRNA) during the priod from July 2013 to June 2016 were recruited in this study. Results: Prevalence of positive high risk (HR) HPV DNA and mRNA test were 19.7 and 8.4%, respectively with a statistically significant difference. Majority of cases of abnormal cytology in this study were atypical squamous cells of undetermined significance (ASC-US). In patients with ASC-US, positive HR HPV DNA was greater than in the mRNA group (10.1 and 4.5%, p
format article
fullrecord <record><control><sourceid>kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO201617847603395</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JAKO201617847603395</sourcerecordid><originalsourceid>FETCH-kisti_ndsl_JAKO2016178476033953</originalsourceid><addsrcrecordid>eNqNj81KxDAURoMoWHTe4W5cFtomk4zLsYwUFZX5EXdDpk07l0mTMTcO9hl8abtw4dLV4YPDB-eMJYVQMlWyeD9nST7Neaq4nF2yCRHuMiEUz6QQCftefB1NQONqA76F0vc7dKaBJ_z4xAbuNI2jNOGEtbZQDtFb3w2gXQMVdvt0iXSA6vUN-uXzHFof_sh6PA2wqoMxDl0H6GC9132vSUfYODyZQBgHqDwdMWp7zS5abclMfnnFbu4X67JKD0gRt64hu32YP74UWS5zNRsDM85vp_y_3g895lPW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital</title><source>Open Access: PubMed Central</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Muangto, Teerapat ; Chanthasenanont, Athita ; Lertvutivivat, Supapen ; Nanthakomon, Tongta ; Pongrojpaw, Densak ; Bhamarapravatana, Kornkarn ; Suwannarurk, Komsun</creator><creatorcontrib>Muangto, Teerapat ; Chanthasenanont, Athita ; Lertvutivivat, Supapen ; Nanthakomon, Tongta ; Pongrojpaw, Densak ; Bhamarapravatana, Kornkarn ; Suwannarurk, Komsun</creatorcontrib><description>Background: Cervical cancer is the second most common of malignancy found in Thai women. Human papillomavirus (HPV) infection is a major cause. The objective of the present study was to evaluate the prevalence of HPV infection and association with abnormal cervical cytology in Thai women. Materials and Methods: This study was conducted at the Gynecologic Clinic, Thammasat University, Pathum Thani, Thailand. A total of 2,144 cases who underwent annual cervical cancer screening by co-testing (liquid based cytology and HPV testing, DNA versus mRNA) during the priod from July 2013 to June 2016 were recruited in this study. Results: Prevalence of positive high risk (HR) HPV DNA and mRNA test were 19.7 and 8.4%, respectively with a statistically significant difference. Majority of cases of abnormal cytology in this study were atypical squamous cells of undetermined significance (ASC-US). In patients with ASC-US, positive HR HPV DNA was greater than in the mRNA group (10.1 and 4.5%, p&lt;0.001). Nonetheless, there was no significant difference in participants with cervical intraepithelial neoplasia (CIN). HPV mRNA test had slightly lower sensitivity but higher negative predictive value (NPV) than the DNA test to detect abnormal cytology during cervical cancer screening (p&lt;0.001). Both HPV test (DNA and mRNA) had equally efficacy to detect high grade precancerous lesion or higher (CIN 2+). Conclusions: Prevalence of HR HPV DNA and mRNA were 19.7 and 8.4 percent, respectively. NPV of HPV mRNA was higher than DNA test. Both tests had equal efficacy to detect CIN 2+ with sensitivity and specificity of 63% vs 55.7% and 83% vs 92%, respectively.</description><identifier>ISSN: 1513-7368</identifier><identifier>EISSN: 2476-762X</identifier><language>kor</language><ispartof>Asian Pacific journal of cancer prevention : APJCP, 2016, Vol.17 (9), p.4409-4413</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024</link.rule.ids></links><search><creatorcontrib>Muangto, Teerapat</creatorcontrib><creatorcontrib>Chanthasenanont, Athita</creatorcontrib><creatorcontrib>Lertvutivivat, Supapen</creatorcontrib><creatorcontrib>Nanthakomon, Tongta</creatorcontrib><creatorcontrib>Pongrojpaw, Densak</creatorcontrib><creatorcontrib>Bhamarapravatana, Kornkarn</creatorcontrib><creatorcontrib>Suwannarurk, Komsun</creatorcontrib><title>Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital</title><title>Asian Pacific journal of cancer prevention : APJCP</title><addtitle>Asian Pacific journal of cancer prevention : APJCP</addtitle><description>Background: Cervical cancer is the second most common of malignancy found in Thai women. Human papillomavirus (HPV) infection is a major cause. The objective of the present study was to evaluate the prevalence of HPV infection and association with abnormal cervical cytology in Thai women. Materials and Methods: This study was conducted at the Gynecologic Clinic, Thammasat University, Pathum Thani, Thailand. A total of 2,144 cases who underwent annual cervical cancer screening by co-testing (liquid based cytology and HPV testing, DNA versus mRNA) during the priod from July 2013 to June 2016 were recruited in this study. Results: Prevalence of positive high risk (HR) HPV DNA and mRNA test were 19.7 and 8.4%, respectively with a statistically significant difference. Majority of cases of abnormal cytology in this study were atypical squamous cells of undetermined significance (ASC-US). In patients with ASC-US, positive HR HPV DNA was greater than in the mRNA group (10.1 and 4.5%, p&lt;0.001). Nonetheless, there was no significant difference in participants with cervical intraepithelial neoplasia (CIN). HPV mRNA test had slightly lower sensitivity but higher negative predictive value (NPV) than the DNA test to detect abnormal cytology during cervical cancer screening (p&lt;0.001). Both HPV test (DNA and mRNA) had equally efficacy to detect high grade precancerous lesion or higher (CIN 2+). Conclusions: Prevalence of HR HPV DNA and mRNA were 19.7 and 8.4 percent, respectively. NPV of HPV mRNA was higher than DNA test. Both tests had equal efficacy to detect CIN 2+ with sensitivity and specificity of 63% vs 55.7% and 83% vs 92%, respectively.</description><issn>1513-7368</issn><issn>2476-762X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNj81KxDAURoMoWHTe4W5cFtomk4zLsYwUFZX5EXdDpk07l0mTMTcO9hl8abtw4dLV4YPDB-eMJYVQMlWyeD9nST7Neaq4nF2yCRHuMiEUz6QQCftefB1NQONqA76F0vc7dKaBJ_z4xAbuNI2jNOGEtbZQDtFb3w2gXQMVdvt0iXSA6vUN-uXzHFof_sh6PA2wqoMxDl0H6GC9132vSUfYODyZQBgHqDwdMWp7zS5abclMfnnFbu4X67JKD0gRt64hu32YP74UWS5zNRsDM85vp_y_3g895lPW</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Muangto, Teerapat</creator><creator>Chanthasenanont, Athita</creator><creator>Lertvutivivat, Supapen</creator><creator>Nanthakomon, Tongta</creator><creator>Pongrojpaw, Densak</creator><creator>Bhamarapravatana, Kornkarn</creator><creator>Suwannarurk, Komsun</creator><scope>JDI</scope></search><sort><creationdate>2016</creationdate><title>Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital</title><author>Muangto, Teerapat ; Chanthasenanont, Athita ; Lertvutivivat, Supapen ; Nanthakomon, Tongta ; Pongrojpaw, Densak ; Bhamarapravatana, Kornkarn ; Suwannarurk, Komsun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kisti_ndsl_JAKO2016178476033953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muangto, Teerapat</creatorcontrib><creatorcontrib>Chanthasenanont, Athita</creatorcontrib><creatorcontrib>Lertvutivivat, Supapen</creatorcontrib><creatorcontrib>Nanthakomon, Tongta</creatorcontrib><creatorcontrib>Pongrojpaw, Densak</creatorcontrib><creatorcontrib>Bhamarapravatana, Kornkarn</creatorcontrib><creatorcontrib>Suwannarurk, Komsun</creatorcontrib><collection>KoreaScience</collection><jtitle>Asian Pacific journal of cancer prevention : APJCP</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muangto, Teerapat</au><au>Chanthasenanont, Athita</au><au>Lertvutivivat, Supapen</au><au>Nanthakomon, Tongta</au><au>Pongrojpaw, Densak</au><au>Bhamarapravatana, Kornkarn</au><au>Suwannarurk, Komsun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital</atitle><jtitle>Asian Pacific journal of cancer prevention : APJCP</jtitle><addtitle>Asian Pacific journal of cancer prevention : APJCP</addtitle><date>2016</date><risdate>2016</risdate><volume>17</volume><issue>9</issue><spage>4409</spage><epage>4413</epage><pages>4409-4413</pages><issn>1513-7368</issn><eissn>2476-762X</eissn><abstract>Background: Cervical cancer is the second most common of malignancy found in Thai women. Human papillomavirus (HPV) infection is a major cause. The objective of the present study was to evaluate the prevalence of HPV infection and association with abnormal cervical cytology in Thai women. Materials and Methods: This study was conducted at the Gynecologic Clinic, Thammasat University, Pathum Thani, Thailand. A total of 2,144 cases who underwent annual cervical cancer screening by co-testing (liquid based cytology and HPV testing, DNA versus mRNA) during the priod from July 2013 to June 2016 were recruited in this study. Results: Prevalence of positive high risk (HR) HPV DNA and mRNA test were 19.7 and 8.4%, respectively with a statistically significant difference. Majority of cases of abnormal cytology in this study were atypical squamous cells of undetermined significance (ASC-US). In patients with ASC-US, positive HR HPV DNA was greater than in the mRNA group (10.1 and 4.5%, p&lt;0.001). Nonetheless, there was no significant difference in participants with cervical intraepithelial neoplasia (CIN). HPV mRNA test had slightly lower sensitivity but higher negative predictive value (NPV) than the DNA test to detect abnormal cytology during cervical cancer screening (p&lt;0.001). Both HPV test (DNA and mRNA) had equally efficacy to detect high grade precancerous lesion or higher (CIN 2+). Conclusions: Prevalence of HR HPV DNA and mRNA were 19.7 and 8.4 percent, respectively. NPV of HPV mRNA was higher than DNA test. Both tests had equal efficacy to detect CIN 2+ with sensitivity and specificity of 63% vs 55.7% and 83% vs 92%, respectively.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1513-7368
ispartof Asian Pacific journal of cancer prevention : APJCP, 2016, Vol.17 (9), p.4409-4413
issn 1513-7368
2476-762X
language kor
recordid cdi_kisti_ndsl_JAKO201617847603395
source Open Access: PubMed Central; Free E-Journal (出版社公開部分のみ）
title Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A13%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experience%20of%20Combined%20Liquid%20Based%20Cervical%20Cytology%20and%20High-Risk%20HPV%20mRNA%20for%20Cervical%20Cancer%20Screening%20in%20Thammasat%20University%20Hospital&rft.jtitle=Asian%20Pacific%20journal%20of%20cancer%20prevention%20:%20APJCP&rft.au=Muangto,%20Teerapat&rft.date=2016&rft.volume=17&rft.issue=9&rft.spage=4409&rft.epage=4413&rft.pages=4409-4413&rft.issn=1513-7368&rft.eissn=2476-762X&rft_id=info:doi/&rft_dat=%3Ckisti%3EJAKO201617847603395%3C/kisti%3E%3Cgrp_id%3Ecdi_FETCH-kisti_ndsl_JAKO2016178476033953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true